Chiba Prefecture
Records under this name other than the patents Chiba Prefecture holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,193,172 | Method for Predicting Prognosis of Patient with Cancer or Inflammatory Disease Formerly held In force · High confidence | In force | High confidence | |
| US 11,185,593 | Alkylating agent for alkylating target with driver oncogene mutation Lapsed on the fee record Ended Nov 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 30, 2025 | From the USPTO record |
| US 10,751,421 | Alkylating agent for alkylating target with driver oncogene mutation Lapsed on the fee record Ended Aug 25, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 25, 2024 | From the USPTO record |
| US 7,625,711 | Screening method for the identification of a drug for the development of an agent for prevention and/or treatment of Alzheimer's disease Lapsed on the fee record Ended Dec 1, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 1, 2021 | From the USPTO record |
| US 7,601,532 | Microarray for Predicting the Prognosis of Neuroblastoma and Method for Predicting the Prognosis of Neuroblastoma Lapsed on the fee record Ended Oct 13, 2021 · High confidence | Lapsed on the fee record | Ended Oct 13, 2021 | High confidence |
| US 7,087,383 | Nucleic Acid Sequences Showing Enhanced Expression in Benign Neuroblastoma Compared with Acritical Human Neuroblastoma Term ended Term ended Mar 2, 2021 · High confidence | Term ended | Term ended Mar 2, 2021 | High confidence |
| US 7,429,451 | Nucleic acids isolated from stage 4 neuroblastoma Formerly held Lapsed on the fee record Ended Sep 30, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2020 | From the USPTO record |
| US 8,202,690 | Cancer Marker and Therapeutic Agent for Cancer Lapsed on the fee record Ended Jun 19, 2020 · High confidence | Lapsed on the fee record | Ended Jun 19, 2020 | High confidence |
| US 7,384,750 | Nucleic Acid Sequences Having Characteristics of Enhanced Expression in Human Neuroblastoma with Favorable Prognosis Based on Comparison Between Human Neuroblastoma with Favorable Prognosis and Human Neuroblastoma with Unfavorable Prognosis Lapsed on the fee record Ended Jun 10, 2020 · High confidence | Lapsed on the fee record | Ended Jun 10, 2020 | High confidence |
| US 7,335,755 | Nucleic Acids Isolated in Neuroblastoma Lapsed on the fee record Ended Feb 26, 2020 · High confidence | Lapsed on the fee record | Ended Feb 26, 2020 | High confidence |